Apimeds Pharmaceuticals US (APUS) vs Redhill Biopharma (RDHL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Apimeds Pharmaceuticals US is the larger company by market cap ($8.3 million vs $5.1 million), about 1.6 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | APUS | RDHL |
|---|---|---|
| Share price | $5.51 | $0.578 |
| Market cap | $8.32M | $5.14M |
| 1-day change | -21.84% | +21.94% |
| YTD return | -66.40% | — |
| 1-year return | -70.53% | — |
| Forward P/E | — | 19.27 |
| EPS (TTM) | $-36.03 | $0.00 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $59.70 | $2.14 |
| 52-week low | $1.51 | $0.435 |
| Distance from 52-week high | -90.77% | -72.99% |
| Average volume | 3.67M | 2.05M |
| Shares outstanding | 1.51M | 8.89M |
| Employees | — | 13 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Apimeds Pharmaceuticals US
APUS stock →Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure.
Health Care · Biotechnology: Pharmaceutical Preparations
About Redhill Biopharma
RDHL stock →RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company develops and commercializes Talicia for the treatment of H.
Health Care · Biotechnology: Pharmaceutical Preparations · 13 employees
APUS vs RDHL FAQ
Which is bigger, Apimeds Pharmaceuticals US or Redhill Biopharma?
Apimeds Pharmaceuticals US (APUS) is larger, with a market capitalization of $8.32M compared with $5.14M for Redhill Biopharma (RDHL).
Are Apimeds Pharmaceuticals US and Redhill Biopharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.